The FRED flow-diverter stent for intracranial aneurysms: clinical study to assess safety and efficacy.

ABSTRACT:

Background and purpose

Flow-diverter stents are emerging for the endovascular treatment of difficult-to-treat or otherwise untreatable cerebral aneurysms (wide-neck, fusiform, dissecting, blisterlike, or giant). We assessed the clinical safety and efficacy of the Flow-Redirection Endoluminal Device.

Materials and methods

This was an institutional review board-approved single-center observational clinical study in 29 patients with 34 aneurysms elected to be treated by endovascular intervention. After providing informed consent, patients were included according to the following criteria: aneurysm fundus-to-neck ratio <2 or neck diameter >4 mm, fusiform, dissecting, or giant aneurysms. The primary end point for clinical safety was the absence of death, absence of major or minor

SUBMITTER: Mohlenbruch MA 

PROVIDER: S-EPMC8013015 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature